Ignite Creation Date:
2025-12-25 @ 4:06 AM
Ignite Modification Date:
2026-01-04 @ 4:56 PM
Study NCT ID:
NCT02942420
Status:
UNKNOWN
Last Update Posted:
2017-05-18
First Post:
2016-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bucillamine Phase 2 Trial in Patients With Cystinuria
Sponsor:
Revive Therapeutics, Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2018-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2018-03
Completion Date Type:
ESTIMATED
First Submit Date:
2016-10-19
First Submit QC Date:
None
Study First Post Date:
2016-10-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-16
Last Update Post Date:
2017-05-18
Last Update Post Date Type:
ACTUAL